1-3 of 3
Yongzhi Cui, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intent-to-Treat Results of a Phase I Trial of CD19 Chimeric Antigen Receptor Engineered T Cells Using a Consistent Treatment Regimen Reveals a 67% Complete Response Rate in Relapsed, Refractory Acute Lymphoblastic Leukemia

Daniel W. Lee, MD, Maryalice Stetler-Stevenson, MD PhD, Marianna Sabatino, MD, Constance Yuan, MD PhD, Terry J Fry, MD, Nirali N Shah, MD, Cindy Delbrook, RN, Bonnie Yates, RN, Hua Zhang, PhD, Ling Zhang, Nick Tschernia, BS, Yongzhi Cui, MD PhD, Steven Feldman, PhD, James N Kochenderfer, MD, Steven A. Rosenberg, MD, PhD, David F. Stroncek, MD, Alan S. Wayne, MD, Crystal L Mackall, MD
Journal: Blood
Blood (2014) 124 (21): 381.
https://doi.org/10.1182/blood.V124.21.381.381
Published: 2014
Journal Articles

The T Cell Receptor As An Oncogene: Thymic Expression Of Self-Reactive T Cell Receptors Targeting Survivin Induces T-Cell Lymphoblastic Leukmia

Yongzhi Cui, MD, PhD., Masahiro Onozawa, MD, PhD., Leigh Samsel, MS, Haven Garber, M.D., Hua Zhang, Haiying Qin, MS, Terry J Fry, MD, J. Philip McCoy, PhD, Xiaolin Wu, Ph.D., Peter D Aplan, MD, Crystal L Mackall, MD
Journal: Blood
Blood (2013) 122 (21): 167.
https://doi.org/10.1182/blood.V122.21.167.167
Published: 2013
Journal Articles

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

Masahiro Onozawa, MD, PhD., Hyunkyung Kim, MD, PhD., Sheryl M Gough, BSc, PhD, Yingwei Lin, MD., PhD., Yongzhi Cui, MD, PhD., Sarah H Beachy, PhD, Crystal L Mackall, MD, Peter Aplan, MD
Journal: Blood
Blood (2012) 120 (21): 1323.
https://doi.org/10.1182/blood.V120.21.1323.1323
Published: 2012